Corticosteroid induced osteoporosis : guidelines for treatment
Sambrook, P. N., Diamond, T., Ferris, L., Fiatarone-Singh, M., Flicker, L., MacLennan, A., Nowson, Caryl, O'Neill, S. and Greville, H. 2001, Corticosteroid induced osteoporosis : guidelines for treatment, Australian family physician, vol. 30, no. 8, pp. 793-796.
(Some files may be inaccessible until you login with your Deakin Research Online credentials)
BACKGROUND: Last year, Australian Family Physician published Guidelines for Management of Postmenopausal Osteoporosis'. which were developed by Osteoporosis Australia. Recently, significant advances in our understanding of the treatment of corticosteroid osteoporosis have occurred.
OBJECTIVE: The following guidelines also developed by Osteoporosis Australia, and supported by the National Asthma Campaign, are to help general practitioners identify those patients at risk of this problem and to provide information about current treatment strategies. DISCUSSION: Corticosteroids are widely used and effective agents for the control of many inflammatory diseases. Corticosteroid osteoporosis is a common problem associated with the long term high dose use of these medications.
Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners.
Unless expressly stated otherwise, the copyright for items in Deakin Research Online is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact email@example.com.